The synthesis of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex several-stage organic process. Initial routes focused on amino acid chain fragment coupling, utilizing solid-phase creation methodologies to build the long peptide sequence. Subsequent research has explored different approaches, includi